Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS).
We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
Reporting to the VP, Market Access and Reimbursement, the Senior Manager, has in-depth expertise in developing and implementing strategic and tactical reimbursement/market access initiatives in the US and/or internationally. A key focus of this position is to collaborate with U.S. facility customers (Hospitals & ASCs) as well as Medicare Administrative Contractors (MACs) in support of the Medicare Transitional Pass-Through Payment for HF10 therapy. The role is also focused on supporting internal and external customers as well as key stakeholders in all aspects of the reimbursement process. The candidate is highly skilled at developing relationships as well as working across the organization to achieve reimbursement and patient access goals that are aligned with sales and marketing strategies.